TipRanks
Go Ultimate55% OFF

Global Health Limited (GLH) AI Stock Analysis

AU:GLH

Global Health Limited

(ASX:GLH)

Select Model
Rating:38Underperform
Price Target:AUD 0.05â–¼(-7.14% Downside)
Action:downgraded
Date:09/06/26

Poor financial performance is the primary driver of the low score, with weak technicals and stretched valuation adding further pressure.

Positive Factors
Reduced lossesThe substantial reduction in losses from the 2023 trough suggests some operational stabilization and lowers the immediate scale of earnings deterioration. If maintained, this improvement could provide a foundation for future margin recovery, although profitability has not yet been restored.
Negative Factors
Persistent unprofitabilityRepeated annual losses and a negative TTM net margin show that the business has not established a durable profit engine. Ongoing operating losses weaken retained capital, limit internal funding capacity, and make future performance dependent on a successful margin recovery.

Global Health Limited (GLH) vs. iShares MSCI Australia ETF (EWA)

-60%-50%-40%-30%-20%-10%0%10%20%AU:GLH-43.43%EWA+14.93%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 3.31M
Dividend Yield
―
Average Volume (3M)
20.50K
Price to Earnings (P/E)
61.4
Beta (1Y)
0.15
Revenue Growth
-1.84%
EPS Growth
13.42%
Country
Australia
Employees
49
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Global Health Limited Business Overview & Revenue Model

Company Description

Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specia...

Global Health Limited Financial Statement Overview

Summary

Volatile revenue, negative margins, deeply negative equity, and continued cash burn point to significant financial risks despite modest cash flow improvements.

Income Statement

25Negative

Balance Sheet

12Very Negative

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue7.18M7.18M8.67M8.12M7.82M6.54M
Gross Profit-566.57K-566.58K2.10M-689.94K-2.18M-664.00K
EBITDA-1.39M-1.39M-793.08K-1.77M-7.19M-1.69M
Net Income-758.22K-758.22K-866.63K-1.31M-8.05M-2.05M
Balance Sheet
Total Assets1.98M1.98M2.84M3.08M3.12M11.03M
Cash, Cash Equivalents and Short-Term Investments738.07K738.07K1.38M2.07M2.24M6.38M
Total Debt1.63M1.63M1.46M1.03M44.94K141.83K
Total Liabilities6.43M6.43M6.58M5.98M4.74M4.95M
Stockholders Equity-4.45M-4.45M-3.73M-2.90M-1.62M6.09M
Cash Flow
Free Cash Flow-207.03K-207.03K-706.63K-1.15M-4.36M-2.08M
Operating Cash Flow-196.27K-196.27K-706.63K-1.13M-3.46M-1.18M
Investing Cash Flow-10.76K-10.76K5,000-17.48K-902.77K-778.93K
Financing Cash Flow-424.65K-424.65K-10.70K982.56K240.86K3.50M

Global Health Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price0.06

Price Trends

50DMA0.06Positive
100DMA0.06Positive
200DMA0.06Negative

Market Momentum

MACD0.00Positive
RSI68.98Neutral
STOCH68.97Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GLH, the sentiment is Positive. The current price of 0.06 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.06, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 68.98 is Neutral, neither overbought nor oversold. The STOCH value of 68.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:GLH.

Global Health Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AU:GLH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AU:RHCAU:RHC58NeutralAUD 12.77B40.886.58%1.64%4.36%4799.64%
AU:REGAU:REG55NeutralAUD 1.45B26.00-264.68%3.83%16.55%13.42%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU:EPNAU:EPN47NeutralAUD 7.78M66.673.34%―121.40%―
AU:PGCAU:PGC43NeutralAUD 256.57M-16.14-5.34%―1.84%-178.23%
AU:FCGAU:FCG41NeutralAUD 4.01M-10.21-41.70%―-97.98%91.33%
AU:GLHAU:GLH38UnderperformAUD 3.25M61.3714.48%―-1.84%13.42%

* Healthcare Sector Average

Performance Comparison

-50%0%50%AU:GLHAU:EPNAU:RHCAU:PGCAU:REGAU:FCGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:GLH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:GLHGlobal Health Limited0.06-0.05-46.67%
AU:EPNEpsilon Healthcare Limited0.02-0.00-16.67%
AU:RHCRamsay Health Care Limited55.7524.9580.99%
AU:PGCParagon Care Limited0.15-0.17-51.56%
AU:REGRegis Healthcare Ltd.4.86-2.36-32.71%
AU:FCGFreedom Care Group Holdings Limited0.040.000.00%

Global Health Limited Corporate Events

Global Health Reshapes Company Secretarial Team to Bolster ASX Compliance

Oct 27, 2026

Global Health Limited has announced a change in its corporate governance team, with Christopher Fernandes resigning as Joint Company Secretary and Lachlan Morley stepping into the role alongside continuing Joint Company Secretary Anara Malabekova. Mo...

Global Health Cuts Costs and Improves Cashflow on AI-Driven Efficiency

Oct 26, 2026

Global Health Limited reported a marked improvement in cash metrics for the quarter and 12 months to 30 September 2026, highlighted by a 22% reduction in quarterly operating cash outflow and strong cash receipts of over $1.6 million in October, leavi...

Global Health boosts SaaS revenue and trims costs in FY2026 upgrade

Aug 27, 2026

Global Health Limited reported full-year FY2026 results showing a strategic shift toward higher-quality recurring revenue and improved profitability metrics despite remaining loss-making. Core annual recurring revenue, including expansion revenue, ro...

Global Health Limited Strengthens Corporate Governance Framework

Aug 27, 2026

Global Health Limited has detailed a comprehensive corporate governance framework that emphasises ethical standards, clear values and diversity across its organisation. The board’s composition and responsibilities are formally defined, with dis...

Global Health Files Updated ASX Corporate Governance Statement

Aug 27, 2026

Global Health Limited has lodged its updated corporate governance statement and Appendix 4G with the ASX for the financial year ended 30 June 2026. The statement, current as of 27 August 2026, is hosted on the company’s website and has been app...

Global Health Loss Narrows but Going-Concern Doubts Persist

Aug 27, 2026

Global Health Limited reported a 1.84% decline in revenue from ordinary activities to A$7.18 million for the year ended 30 June 2026, while its net loss narrowed to A$758,220 from A$866,632 a year earlier. The company did not pay, recommend or declar...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026